Status:
COMPLETED
Effect of Prophylactic Ketorolac on CME After Cataract Surgery
Lead Sponsor:
Queen's University
Conditions:
Macular Edema, Cystoid
Eligibility:
All Genders
Phase:
NA
Brief Summary
The study will evaluate the efficacy of prophylactic administration of the topical nonsteroidal anti-inflammatory drug (NSAID) ketorolac tromethamine 0.5% (Acular®) on cystoid macular edema (CME) in p...
Eligibility Criteria
Inclusion
- First cataract surgery (i.e., first eye).
Exclusion
- hypersensitivity to the NSAID drug class,
- pregnancy.
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT00335439
Start Date
June 1 2006
End Date
May 1 2007
Last Update
January 13 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hotel Dieu Hospital
Kingston, Ontario, Canada, K7L 5G2